Wikidata

(Q58030165)

English

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study

scientific article published on 11 May 2011

In more languages

Statements

title
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21562045
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562045%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q58030165&oldid=1998572286"